These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10605476)

  • 41. Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes.
    Choi MS; Yun SJ; Beom HJ; Park HR; Lee JB
    J Dermatol; 2011 Jul; 38(7):661-6. PubMed ID: 21352326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of neutrophil chemotactic factor production in comedonal bacteria by subminimal inhibitory concentrations of erythromycin.
    Akamatsu H; Kurokawa I; Nishijima S; Asada Y
    Dermatology; 1992; 185(1):41-3. PubMed ID: 1386264
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propionibacterium acnes is developing gradual increase in resistance to oral tetracyclines.
    Nakase K; Nakaminami H; Takenaka Y; Hayashi N; Kawashima M; Noguchi N
    J Med Microbiol; 2017 Jan; 66(1):8-12. PubMed ID: 28218057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical effectiveness of once-daily levofloxacin for inflammatory acne with high concentrations in the lesions.
    Kawada A; Wada T; Oiso N
    J Dermatol; 2012 Jan; 39(1):94-6. PubMed ID: 21545499
    [No Abstract]   [Full Text] [Related]  

  • 45. Peptides with antimicrobial and anti-inflammatory activities that have therapeutic potential for treatment of acne vulgaris.
    Popovic S; Urbán E; Lukic M; Conlon JM
    Peptides; 2012 Apr; 34(2):275-82. PubMed ID: 22374306
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythromycin-resistance of cutaneous bacterial flora in acne.
    Dreno B; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2001; 11(6):549-53. PubMed ID: 11701406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Robust evidence is needed in treating acne.
    Garner S; Eady A; Avery T
    BMJ; 2002 Dec; 325(7377):1422. PubMed ID: 12480866
    [No Abstract]   [Full Text] [Related]  

  • 48. Skin Ecology during Sebaceous Drought-How Skin Microbes Respond to Isotretinoin.
    McCoy WH; Otchere E; Rosa BA; Martin J; Mann CM; Mitreva M
    J Invest Dermatol; 2019 Mar; 139(3):732-735. PubMed ID: 30579608
    [No Abstract]   [Full Text] [Related]  

  • 49. Treating acne in women.
    O'Donoghue MN
    Cutis; 2010 Nov; 86(5):222-3. PubMed ID: 21214119
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effects of macrolide therapy on patients with acne vulgaris].
    Akamatsu H
    Jpn J Antibiot; 2001 Feb; 54 Suppl A():109-12. PubMed ID: 11439886
    [No Abstract]   [Full Text] [Related]  

  • 51. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W; Stoughton RB
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clonality and anatomic distribution on the skin of antibiotic resistant and sensitive Propionibacterium acnes.
    Lomholt HB; Kilian M
    Acta Derm Venereol; 2014 Sep; 94(5):534-8. PubMed ID: 24577497
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of Propionibacterium acnes in acne pathogenesis: facts and controversies.
    Dessinioti C; Katsambas AD
    Clin Dermatol; 2010; 28(1):2-7. PubMed ID: 20082942
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibiotics and acne: an emerging iceberg of antibiotic resistance?
    Sinnott SJ; Bhate K; Margolis DJ; Langan SM
    Br J Dermatol; 2016 Dec; 175(6):1127-1128. PubMed ID: 27996153
    [No Abstract]   [Full Text] [Related]  

  • 55. Reduction of bacterial skin flora during oral treatment of severe acne with 13-cis retinoic acid.
    Weissmann A; Wagner A; Plewig G
    Arch Dermatol Res; 1981; 270(2):179-83. PubMed ID: 6454395
    [No Abstract]   [Full Text] [Related]  

  • 56. Chemical composition and biological activities of Jeju Thymus quinquecostatus essential oils against Propionibacterium species inducing acne.
    Oh TH; Kim SS; Yoon WJ; Kim JY; Yang EJ; Lee NH; Hyun CG
    J Gen Appl Microbiol; 2009 Feb; 55(1):63-8. PubMed ID: 19282635
    [No Abstract]   [Full Text] [Related]  

  • 57. Treating acne with antibiotic-resistant bacterial colonization.
    Tzellos T; Zampeli V; Makrantonaki E; Zouboulis CC
    Expert Opin Pharmacother; 2011 Jun; 12(8):1233-47. PubMed ID: 21355786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Staphylococcus epidermidis: A Potential New Player in the Physiopathology of Acne?
    Claudel JP; Auffret N; Leccia MT; Poli F; Corvec S; Dréno B
    Dermatology; 2019; 235(4):287-294. PubMed ID: 31112983
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H
    Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acne and risk of prostate cancer.
    Sutcliffe S; Giovannucci E; Isaacs WB; Willett WC; Platz EA
    Int J Cancer; 2007 Dec; 121(12):2688-92. PubMed ID: 17724724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.